Psyence Group Inc. PSYGF
Set alert
At close · Aug 6
- YTD
- +9.76%
- 1 year
- +19.66%
- Open
- 0.127
- Prev close
- 0.1394
- Mkt cap
- 2.25M
- Vol
- 100
- Avg vol
- 81
- EPS
- -0.36288
- P/E
- -0.38
More statistics
- Low
- 0.127
- High
- 0.1394
News
4 days ago newsfilecorp.com
Airborne Magnetic Survey Generates 22 Priority Gold Exploration Targets
Phase I Exploration Program Completed Marine Survey to Explore Priority Magnetic Targets Toronto, Ontario--(Newsfile Corp. - October 27, 2026) - GoldCoast Resource Corp. (CSE: GCR) (OTC: GCRFF) (FSE:…
5 days ago newsfilecorp.com
GoldCoast Resource Corp. to Present at the Red Cloud Fall Mining Showcase 2026
Toronto, Ontario--(Newsfile Corp. - October 26, 2026) - GoldCoast Resource Corp. (CSE: GCR) (OTC: GCRFF) (FSE: EKW) ("GoldCoast" or the "Company") is pleased to announce that it will participate in…
1 week ago globenewswire.com
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that both milestones attached to its backstop subscription…
1 week ago newsfilecorp.com
GoldCoast Resource Corp. Confirms Government of Ghana to Issue Public Statement Clarifying GoldCoast's Licenses Have Not Been Suspended
Company Chairman & Corporate Counsel met with regulatory authorities in Accra following October 9 letter to the National Fisheries Association of Ghana Accra, Ghana and Toronto, Ontario--(Newsfile…
2 weeks ago newsfilecorp.com
GoldCoast Resource Corp. Announces Trading Halt Pending Clarification from Government of Ghana
Toronto, Ontario--(Newsfile Corp. - October 14, 2026) - GoldCoast Resource Corp. (CSE: GCR) (OTCQB: GCRFF) (FSE: EKW) ("GoldCoast" or the "Company") announces that it has requested a halt in trading…
3 weeks ago newsfilecorp.com
GoldCoast Resource Corp. Clarifies Media Reports and Confirms Offshore Licenses Remain in Good Standing
Toronto, Ontario--(Newsfile Corp. - October 8, 2026) - GoldCoast Resource Corp. (CSE: GCR) (OTCQB: GCRFF) (FSE: EKW) ("GoldCoast" or the "Company") is issuing this release to correct recent reports…
3 weeks ago globenewswire.com
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade ibogaine as TIRC advances its planned U.S. development program Partnership intended to establish a…
1 month ago newsfilecorp.com
GoldCoast Resource Corp. to Commence Trading on the OTCQB Venture Market
Toronto, Ontario--(Newsfile Corp. - September 29, 2026) - GoldCoast Resource Corp. (CSE: GCR) (OTCQB: GCRFF) ("GoldCoast" or the "Company") is pleased to announce that it has been approved to…
1 month ago globenewswire.com
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
Binding term sheet with PsyLabs provides Psyence BioMed's Texas subsidiary with exclusive U.S. development, supply and distribution rights to PsyLabs' pharmaceutical-grade ibogaine, subject to a…
1 month ago globenewswire.com
Psyence BioMed Announces Strategic Ibogaine Investment
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange Highlights The Company is actively advancing plans for a potential…
1 month ago globenewswire.com
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
HIGHLIGHTS Texas-based company established as dedicated U.S. vehicle for regulated ibogaine development Positioned to hold U.S. rights to PsyLabs' pharmaceutical-grade ibogaine, subject to completion…
2 months ago globenewswire.com
Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built Company says growing federal commitment to…
5 months ago accessnewswire.com
Psyence Group Inc. Announces Results of Annual General and Special Meeting of Shareholders
TORONTO, ON / ACCESS Newswire / May 21, 2026 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") is pleased to announce the voting results from its annual general and special meeting of…
5 months ago globenewswire.com
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived…
6 months ago globenewswire.com
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin candidate across an expanded Australian site network Dosing initiates clinical evaluation of NPX-5, a…
6 months ago globenewswire.com
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
Through its investment in and collaboration with PsyLabs, the Company has established a GMP-compliant, pharmaceutical-grade supply chain Through its investment in and collaboration with PsyLabs, the…
6 months ago globenewswire.com
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supply Company highlights global leadership in GMP ibogaine manufacturing and commitment to…
6 months ago globenewswire.com
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine…
7 months ago accessnewswire.com
Psyence Group Announces GoldCoast Resource Closes Second Tranche of Offering
Combined aggregate with previous tranche of $8,603,883 TORONTO, ON / ACCESS Newswire / March 24, 2026 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that GoldCoast Resource…
7 months ago accessnewswire.com
Psyence Group Inc. Provides Update on Proposed Amalgamation with GoldCoast Resource Corp.
GoldCoast Closes First Tranche of Private Placement TORONTO, ON / ACCESS Newswire / March 17, 2026 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that GoldCoast Resource Corp.…